(Total Views: 553)
Posted On: 08/13/2021 12:22:51 AM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: VegasorBust #99871
Bamlanivimab, Tocilizumab, etc. aren't a threat to other BPs, so they get EUAs. Leronlimab, on the other hand, is a definite threat and must be withheld from the market as long as politically possible. Deaths from this virus don't matter as long as BP is happy.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)